Pioneering the clinical study of psilocybin, LSD, and other substances, this program investigates their therapeutic potential for mental health conditions like depression, PTSD, and addiction. Researchers guide participants through carefully controlled sessions to explore healing applications. Patients with treatment-resistant disorders, alongside the broader medical community, benefit from emerging evidence supporting new therapeutic pathways.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends